TF and cancer: This was supported by observations that cancer patients with VTE presented with increased TF-EV coagulant activity or increased TF+ EVs (Tesselaar et al., 2007; Tesselaar et al., 2009; Zwicker et al., 2009; Manly et al., 2010; Geddings and Mackman, 2013).